» Articles » PMID: 31300526

Investigation of Serum Proteome Homeostasis During Radiation Therapy by a Quantitative Proteomics Approach

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2019 Jul 14
PMID 31300526
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of the present study is to analyze the serum proteome of patients receiving Radiation Therapy (RT) at different stages of their treatment to discovery candidate biomarkers of the radiation-induced skin lesions and the molecular pathways underlying the radiation signatures. Six stages of RT treatment were monitored from patients treated because of brain cancer: before starting the treatment, during the treatment (four time points), and at 4 weeks from the last RT dose. Serum samples were analyzed by a proteomics approach based on the Data Independent Acquisition (DIA) mass spectrometry (MS). RT induced clear changes in the expression levels of 36 serum proteins. Among these, 25 proteins were down- or up-regulated significantly before the emergence of skin lesions. Some of these were still deregulated after the completion of the treatment. Few days before the appearance of the skin lesions, the levels of some proteins involved in the wound healing processes were down-regulated. The pathway analysis indicated that after partial body irradiation, the expression levels of proteins functionally involved in the acute inflammatory and immune response, lipoprotein process and blood coagulation, were deregulated.

Citing Articles

Insights into Medication-Induced Osteonecrosis of the Jaw Through the Application of Salivary Proteomics and Bioinformatics.

Schwartzova V, Laputkova G, Talian I, Marcin M, Schwartzova Z, Glaba D Int J Mol Sci. 2024; 25(22).

PMID: 39596473 PMC: 11594355. DOI: 10.3390/ijms252212405.


Cross-platform validation of a mouse blood gene signature for quantitative reconstruction of radiation dose.

Ghandhi S, Shuryak I, Ponnaiya B, Wu X, Garty G, Morton S Sci Rep. 2022; 12(1):14124.

PMID: 35986207 PMC: 9391341. DOI: 10.1038/s41598-022-18558-1.


Age and sex effects across the blood proteome after ionizing radiation exposure can bias biomarker screening and risk assessment.

Langen B, Vorontsov E, Spetz J, Swanpalmer J, Sihlbom C, Helou K Sci Rep. 2022; 12(1):7000.

PMID: 35487913 PMC: 9055069. DOI: 10.1038/s41598-022-10271-3.


MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.

Song Y, Xu X, Wang N, Zhang T, Hu C J Clin Lab Anal. 2022; 36(4):e24254.

PMID: 35212031 PMC: 8993654. DOI: 10.1002/jcla.24254.


Review of the Terminology Describing Ionizing Radiation-Induced Skin Injury: A Case for Standardization.

Burnett L, Hughes R, Rejeski A, Moffatt L, Shupp J, Christy R Technol Cancer Res Treat. 2021; 20:15330338211039681.

PMID: 34613833 PMC: 8504211. DOI: 10.1177/15330338211039681.


References
1.
Porock D . Factors influencing the severity of radiation skin and oral mucosal reactions: development of a conceptual framework. Eur J Cancer Care (Engl). 2002; 11(1):33-43. View

2.
Udby L, Cowland J, Johnsen A, Sorensen O, Borregaard N, Kjeldsen L . An ELISA for SGP28/CRISP-3, a cysteine-rich secretory protein in human neutrophils, plasma, and exocrine secretions. J Immunol Methods. 2002; 263(1-2):43-55. DOI: 10.1016/s0022-1759(02)00033-9. View

3.
Udby L, Calafat J, Sorensen O, Borregaard N, Kjeldsen L . Identification of human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils. J Leukoc Biol. 2002; 72(3):462-9. View

4.
Liao Q, Kleeff J, Xiao Y, Guweidhi A, Schambony A, Topfer-Petersen E . Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis. Histol Histopathol. 2003; 18(2):425-33. DOI: 10.14670/HH-18.425. View

5.
Epstein J, Schubert M . Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology (Williston Park). 2004; 17(12):1767-79. View